Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001493152-26-017879
Filing Date
2026-04-17
Accepted
2026-04-17 16:30:33
Documents
19
Period of Report
2026-04-17

Document Format Files

Seq Description Document Type Size
1 PRE 14A formpre14a.htm   iXBRL PRE 14A 866148
2 GRAPHIC chart_001.jpg GRAPHIC 60667
3 GRAPHIC chart_002.jpg GRAPHIC 60667
4 GRAPHIC proxy_001.jpg GRAPHIC 281675
5 GRAPHIC proxy_002.jpg GRAPHIC 443115
  Complete submission text file 0001493152-26-017879.txt   3652297

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abeo-20251231.xsd EX-101.SCH 5447
7 XBRL CALCULATION FILE abeo-20251231_cal.xml EX-101.CAL 896
8 XBRL DEFINITION FILE abeo-20251231_def.xml EX-101.DEF 7300
9 XBRL LABEL FILE abeo-20251231_lab.xml EX-101.LAB 62600
10 XBRL PRESENTATION FILE abeo-20251231_pre.xml EX-101.PRE 45944
22 EXTRACTED XBRL INSTANCE DOCUMENT formpre14a_htm.xml XML 67348
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-15771 | Film No.: 26871997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)